REG-A&D Pharma Hldgs N.V AGM Statement

BUCHAREST, Romania--(Business Wire)--

NOTICE OF ANNUAL GENERAL MEETING OF SHAREHOLDERS

A&D Pharma Holdings N.V. ("A&D Pharma" or the "Company"), the Dutch holding
company that owns the largest integrated pharmaceutical sales and marketing
services, wholesale and retail business in Romania, today announced that the
Annual General Meeting of the Shareholders (AGM) of A&D Pharma will be held on
Friday 24 April 2009 at 10:00 AM (CET) at the Hilton Hotel Amsterdam Airport
Schiphol, Schipholboulevard 701, 1118 Schiphol-centrum, The Netherlands. The
agenda of the AGM is as follows:

1. Opening

2. Discussion of the annual report, including the report of the Board of
Directors for the financial year ended 31 December 2008

3. Adoption of the annual accounts for the financial year ended 31 December 2008

4. Reservation and dividend policy of the Company

5. Appropriation of accrued profit to the financial year ended 31 December 2008

6. Granting of discharge to the Executive Directors for their management during
the financial year 2008

7. Granting of discharge to the Non-Executive Directors for their supervision
during the financial year 2008

8. Authorization of the Board of Directors to appoint the auditors for the
financial year 2009

9. Discussion of the corporate governance policy of the Company

10. Amendment of the Articles of Association

11. Re-appointment of Mr. Walid Abboud, Mr. Ludovic Robert, Mr. Roger Akoury as
Non-Executive Directors of the Company

12. Discussion of the group reorganization process

13. Extension of authorisation of the Board to buy back Global Depository
Receipts and shares of the Company

14. Any other business

15. Closing

All documents related to the AGM, including the Annual Report for the year ended
31 December 2008, Convocation Notice, Shareholders Circular and Form of Proxy
have today been sent to shareholders. The Annual Report for the year ended 31
December 2008 has also been made available on the Company`s website
www.adpharma.ro.

Two copies of the following documents have been submitted to the UK Listing
Authority, and will shortly be available for inspection at the UK Listing
Authority`s Document Viewing Facility at the address shown below:

* Annual Report for the year ended 31 December 2008
* Convocation Notice and Shareholder Circular in connection with the 2009 AGM
* Form of Proxy for the 2009 AGM

UK Listing Authority Document Viewing Facility:

Financial Services Authority,
25 The North Colonnade,
Canary Wharf,
London E14 5HS
Tel: +44 (0)20 7066 8333

For further information, please visit www.adpharma.ro or contact:

A&D Pharma A&D Pharma
Investor Relations Romanian Press Relations
Cristian Barbulescu Veronica Burlacu
Tel: +40 21 301 7474 Tel: +40 726 301 572
cristian.barbulescu@adpharma.ro presa@adpharma.ro

A&D Pharma Shared Value Limited
Corporate Governance and Compliance Investor & Media Relations
Director Nicolas Duperrier / Mark Walter
Mihaela Ciobanescu Tel. +44 (0)20 7321 5010
133 Ciobanului St., Mogosoaia adpharma@sharedvalue.net
Ilfov county, Romania, 077135
Tel: +40 21 301 7434
mihaela.ciobanescu@adpharma.ro

ABOUT A&D PHARMA

A&D Pharma Holdings N.V. is the Dutch holding company of A&D Pharma Holdings
S.R.L., the leading pharmaceutical sales and marketing services, wholesale and
retail business in Romania. Founded in 1994, the Group owns Romania`s leading
pharmaceutical wholesale, sales and marketing services for CHC and Rx products
network "Mediplus", and Romania`s largest national branded chain of pharmacies
"Sensiblu".

The Group`s consolidated sales increased at a compound annual rate of 39%
between 2003 and 2008, amounting to €501.5 million for the twelve months ended

31 December 2008. A&D Pharma`s shares have been traded in the form of Global
Depositary Receipts ("GDRs") on the regulated market of the London Stock
Exchange since October 2006 under the symbol 'ADPH'.

This release is not an offer for sale of the GDRs of A&D Pharma, or any other of
its securities, in the United States or in any jurisdiction where any offer,
sale or solicitation in respect of such securities is not permitted. Securities
may not be offered or sold in the United States absent registration or an
exemption from registration under the US Securities Act of 1933, as amended, or
in any jurisdiction where such offer or sale is not permitted.

Certain statements made in this release are forward looking statements. Such
statements are based on current expectations and are subject to a number of
risks and uncertainties that could cause actual events or results to differ
materially from any expected future events or results referred to in these
forward looking statements.

This release should not be construed as the giving of advice or the making of a
recommendation and should not be relied on as a basis for any decision or
action. In particular, actual results and developments may be materially
different from any forecast, opinion or expectation expressed in this
presentation and the past performance of the price of securities must not be
relied upon as a guide to their future performance.

A&D Pharma Hldgs N.V

Copyright Business Wire 2009